LightSmyth develops innovative nanophotonic products. Target areas include integrated photonics, free-space diffractives, and consumer products. LightSmyth products and innovations are centered around application of holographic and diffractive principles combined with manufacturing via state-of-the-art semiconductor patterning tools such as Deep UltraViolet (DUV) steppers/scanners.
The company is developing a new generation of advanced nonlinear electro-optic and all-optical organic polymers that can convert high-speed electronic signals into optical signals or allow light waves to switch other light waves.
Linkam develops and manufactures a broad range of heating and freezing stages for both OEM and end users to visualize and explore materials properties. Used in conjunction with light microscopes and other forms of spectroscopy, Linkam stages are found in thousands of laboratories worldwide with the most successful heating/freezing stage, the THMS600, selling over 3000 units alone.
The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
Living Cell is developing cell-based products to treat life threatening human diseases. The company has developed proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell, to be implanted without the use of toxic immune suppressive drugs.
The company develops, produces and distributes 3D analysis instruments based on the Digital Holographic Microscopy (DHM) technology. With this technology, microscopes combine nanometric resolution, real-time and non-invasive three dimensional observation